Tvardi Therapeutics, Inc.
TVRD
$3.02
$0.020.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.54% | 286.31% | -- | -2.66% | 37.94% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 909.72% | 56.76% | -- | -- | -97.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -0.47% | 259.18% | -- | -- | 21.13% |
|
|
|||||
| Total Current Assets | -0.47% | 259.18% | -- | -- | 21.13% |
| Net Property, Plant & Equipment | -34.67% | -28.06% | -- | -- | -20.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -16.36% | -15.71% | -- | -- | -14.06% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -99.40% | -98.45% | -- | -- | 16,535.29% |
| Total Assets | -8.88% | 211.82% | -- | -- | 30.36% |
|
|
|||||
| Total Accounts Payable | 47.26% | 106.17% | -- | -- | 35.69% |
| Total Accrued Expenses | -4.59% | 111.58% | -- | -- | 412.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.62% | 22.83% | -- | -- | 10.75% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 6.51% | 108.03% | -- | -- | 215.97% |
|
|
|||||
| Total Current Liabilities | 6.51% | 108.03% | -- | -- | 215.97% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -57.71% | -44.44% | -- | -- | -26.91% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -72.75% | 102.30% | -- | -- | 1,048.12% |
|
|
|||||
| Common Stock & APIC | 11,790.32% | 12,671.35% | -- | -- | 41.49% |
| Retained Earnings | -19.75% | -29.73% | -- | -- | -46.78% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 122.98% | 135.50% | -- | -62.15% | -46.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 122.98% | 135.50% | -- | -62.15% | -46.85% |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 472.17% | 298.09% | -- | -164.50% | -124.01% |
|
|
|||||